Evidence map›Paper›PMID 28666065›Full record

ArticleAngewandte Chemie (International ed. in English)2017

A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells.

Lucien N Lameijer, Daniël Ernst, Samantha L Hopkins, Michael S Meijer, Sven H C Askes, Sylvia E Le Dévédec, Sylvestre Bonnet

Open access · bronzeAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 207 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Light in a Heartbeat: Bond Scission by a Single Photon above 800 nm.Journal of the American Chemical Society · 2024
    Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lucien N LameijerLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.ORCID 0000-0003-2841-4742
Daniël ErnstLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.
Samantha L HopkinsLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.ORCID 0000-0001-8793-4540
Michael S MeijerLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.
Sven H C AskesLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.ORCID 0000-0001-6538-3645
Sylvia E Le DévédecLeiden Academic Centre for Drug Research, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.ORCID 0000-0002-0615-9616
Sylvestre BonnetLeiden Institute of Chemistry, Leiden University, Gorlaeus Laboratories, P.O Box 9502, 2300 RA, Leiden, The Netherlands.ORCID 0000-0002-5810-3657
Leiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe two water-soluble ruthenium complexes, [1]Cl

Indexed as

LightAntineoplastic AgentsCell LineCell ProliferationCell SurvivalCytokinesDose-Response Relationship, DrugDrug Screening Assays, AntitumorEnzyme InhibitorsHumansHypoxiaNicotinamide PhosphoribosyltransferaseOrganometallic CompoundsPhotochemical ProcessesPhotochemotherapyRutheniumAntineoplastic AgentsCytokinesEnzyme InhibitorsNicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, humanOrganometallic CompoundsRutheniumanti-tumor agentshypoxiaphotopharmacologyred-light activationruthenium

Identifiers

PMID28666065
PMCPMC5601216
OpenAlexW2732707479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.